S&CO Inc
- SEC CIK
- 0001082461
- Latest filing
- Aug 6, 2026
RARE holding history
Ultragenyx Pharmaceutical Inc. in every 13F filed by S&CO Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RARE overviewAll 13F holders of RAREFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −25,255−100.0% | Sold out | Holders |
| Q1 2026 | 25,255 | $529.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 25,255 | $580.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 25,255 | $759.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 25,255 | $918.0K | 0.1% | +5,000+24.7% | Added | Holders |
| Q1 2025 | 20,255 | $733.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 20,255 | $852.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 20,255 | $1.13M | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 20,255 | $832.0K | 0.1% | +20,255 | New | Holders |